CALA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CALA Shares Outstanding History and CALA YTD Return |
CALA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CALA Shares Outstanding History and CALA YTD Return |
CALA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-26.86% CAGR Mouse over chart for data details
|
CALA Stock Price Chart |
About Calithera Biosciences, Inc. |
Calithera Biosciences is a clinical-stage precision oncology biopharmaceutical company developing targeted therapies to redefine treatment for biomarker-specific patient populations. Co.'s product candidate, CB-280, is an oral inhibitor of arginase, developed for the treatment of cystic fibrosis. Co. has also identified CB-668, an orally administered inhibitor of the immune-suppressive enzyme IL4I1. An additional arginase inhibitor, INCB001158, was discovered by Co. and is being developed by Incyte Corporation for oncology and hematology indications. Co. has developed CB-708, a selective, orally-bioavailable small molecule inhibitor of CD73. We show 35 historical shares outstanding datapoints in our CALA shares outstanding history coverage, used to compute CALA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CALA market cap history over the course of time is important for investors interested in comparing CALA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CALA versus a peer is one thing; comparing CALA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CALA can fluctuate over the course of history. With this page we aim to empower investors researching CALA by allowing them to research the CALA market cap history. |
CALA Current Stock Quote |
Free CALA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
CALA Share Performance |
Market Cap Peers |
Calithera Biosciences (CALA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CALC Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.